Therapanacea is a leader in AI-driven oncology solutions, focusing on transforming cancer care through advanced mathematics, medical imaging, and engineering. The company collaborates with leading cancer centers worldwide to innovate and validate its clinical applications.
About Therapanacea
Therapanacea develops the ART-Plan™ AI Application Suite, which includes tools for radiotherapy segmentation, automated AI contouring, and AI-driven treatment planning. Their solutions streamline and accelerate high-quality treatment workflows, enabling adaptive radiotherapy and precision medicine strategies.
Medical Imaging Software
Media
No media yet
Screenshots and product tours appear here once the vendor claims this page.
Features
Automate segmentation with AI-based automatic delineation
Generate AI-driven treatment plans
Perform adaptive automated replan assessment
Integrate seamlessly into clinical workflows
Reduce manual tasks by over 93%
Support multi-modality imaging including CT, MR, PET
Provide expert-level radiotherapy plans in minutes
Ensure physician acceptance with clinically evaluated models